March 06, 2026

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

Conexiant

March 06, 2026

Digital Tool Cuts Antibiotic Prescribing

Pragmatic trial finds digital decision support reduces antibiotic use in Rwandan health centers

Conexiant

March 04, 2026

Pneumonia Patterns Postpandemic

Pneumococcal and RSV RAD-CAP incidence increased as SARS-CoV-2 incidence declined, disproportionately affecting older adults.

Conexiant

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

March 02, 2026

Sepsis Antibiotic Timing Shows Physician Divide

Emergency department physicians differ in how quickly they initiate antibiotics for suspected sepsis.

Conexiant

February 27, 2026

Children With OSA Face Higher Influenza, COVID-19 Risk

Real-world analysis finds higher risk of influenza and COVID-19 diagnoses over five years, with no evidence of reduced risk after adenotonsillectomy

Conexiant

February 25, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

Conexiant

February 20, 2026

COVID Vaccine in Pregnancy: Link to Development? 

Multicenter study finds equivalent ASQ-3 scores at 18–30 months in offspring of vaccinated and unvaccinated mothers

Conexiant

February 19, 2026

Quality of Life in Cardiac Arrest Recovery

Post–cardiac arrest care is increasingly structured around survivorship, with standardized patient-reported assessments supporting multidisciplinary follow-up.

Conexiant

February 19, 2026

BP Targets Across CKM Stages

Investigators assess stage-specific outcomes, safety, and net benefit of intensive blood pressure control in cardiovascular-kidney-metabolic syndrome.

Conexiant